Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Preconditioning for Myocardial Protection After Cardiopulmonary Bypass in the Elderly
TCTR20200417004Phase 4Not yet recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in Myocardial injury, sponsored by Ratchadaphiseksomphot Endowment Fund. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on TCTR20200417004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200417004.